|
1.
|
David Goeddel is a molecular biologist who was involved in engineering synthetic insulin, human tissue plasminogen activator (tPA), and human growth hormone. He worked fo [...]
2003 |
Text |
|
|
2.
|
Keith Yamamoto has spent his entire professional career at UCSF, starting in 1973 as a postdoctoral fellow in the Department of Biochemistry and Biophysics and rising to [...]
2020 |
Text |
|
|
3.
|
This oral history with Keith Yamamoto is one in a series documenting science and technology in Northern California. Its focus is Yamamoto’s years in the UCSF Department [...]
2018 |
Text |
|
|
4.
|
This series of interviews documents William J. Rutter's view of his years, 1981-1999, as cofounder and chairman of Chiron Corporation, a San Francisco Bay Area biotechnol [...]
2015 |
Text |
|
|
5.
|
Michael Urdea is a biochemist who helped develop branched DNA signal amplification (bDNA), which resulted in the creation of tests for hepatitis B, hepatitis C, and HIV. [...]
2008 |
Text |
|
|
6.
|
William Green is a lawyer and was the senior vice president and general counsel for Chiron Corporation. He received a bachelor’s degree in political science from Yale U [...]
2008 |
Text |
|
|
7.
|
William Young is a chemical engineer and was the chief operating officer at Genentech. Young was hired by the pharmaceutical company Eli Lilly in the 1960s, where he work [...]
2006 |
Text |
|
|
8.
|
Axel Ullrich is a molecular biologist and cancer researcher, and the former director of the Molecular Biology Department at the Max Planck Institute of Biochemistry. Afte [...]
2006 |
Text |
|
|
9.
|
Riggs, a chemist turned molecular biologist at City of Hope Medical Center in Duarte California, discusses his contributions to research for Genentech on the hormones som [...]
2006 |
Text |
|
|
10.
|
David Martin was a prominent member of the second generation of Genentech scientists. He arrived in 1983, seven years after the company’s formation, to assume the title [...]
2006 |
Text |
|
